ClinicalTrials.gov record
Recruiting Phase 3 Interventional Accepts healthy volunteers

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

ClinicalTrials.gov ID: NCT07446439

Public ClinicalTrials.gov record NCT07446439. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Thetis Study: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Tradipitant on Nausea and Vomiting After GLP-1R Agonist Administration in Healthy Overweight or Obese Volunteers

Study identification

NCT ID
NCT07446439
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vanda Pharmaceuticals
Industry
Enrollment
280 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Tradipitant Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 26, 2026
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026
Last update posted
Apr 19, 2026

2026

United States locations

U.S. sites
10
U.S. states
6
U.S. cities
10
Facility City State ZIP Site status
Vanda Investigational Site Los Angeles California 90025 Recruiting
Vanda Investigational Site San Diego California 92108 Recruiting
Vanda Investigational Site San Jose California 95124 Not yet recruiting
Vanda Investigational Site Tampa Florida 33613 Recruiting
Vanda Investigational Site Hamilton New Jersey 08690 Not yet recruiting
Vanda Investigational Site New York New York 10016 Not yet recruiting
Vanda Investigational Site Syosset New York 11791 Not yet recruiting
Vanda Investigational Site Plano Texas 75024 Not yet recruiting
Vanda Investigational Site San Antonio Texas 78215 Not yet recruiting
Vanda Investigational Site Burke Virginia 22015 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07446439, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 19, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07446439 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →